FDA Boosts Development Of OTC COVID-19 Tests With New Template
Executive Summary
A new template from the US FDA explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.
You may also be interested in...
FDA Authorizes Yale’s SalivaDirect '$10' Rapid COVID-19 Test
The agency says the test is “groundbreaking.” The Yale School of Public Health is giving away the test methodology, which can be run with equipment labs already have.
First US Home Collection COVID-19 Test Gets Green Light
US regulators have authorized the first COVID-19 test that lets people take a sample of mucus inside their nose at home to check for the novel coronavirus. The maker of the test, LabCorp, says the test will be available in most states within the next few weeks – but health care workers will be given the tests before the general public.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.